Braze, Inc. (BRZE) stock
BRZENasdaqServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 10/3064% above fair value
$46.57−0.07 (-0.15%)
Close on Nov 16, 2026Market cap $5.29BP/E –Yield –
Braze r&d expenses
Research and development expenses are spending on new products and technology.
Braze's R&D Expenses for the twelve months ending Jul 31, 2026 was $180.47M, up 24.9% year over year. For fiscal 2026 it was $167.14M, up 24.8% from the year before. The highest annual figure on record is $167.14M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $167.14M | +24.8% |
| FY2025 | Jan 31, 2025 | $133.97M | +11.8% |
| FY2024 | Jan 31, 2024 | $119.86M | +23.2% |
| FY2023 | Jan 31, 2023 | $97.29M | +64.8% |
| FY2022 | Jan 31, 2022 | $59.03M | +102.1% |
| FY2021 | Jan 31, 2021 | $29.21M | +43.6% |
| FY2020 | Jan 31, 2020 | $20.34M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $45.28M | +9.8% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $46.10M | +25.3% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $45.03M | +34.0% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $44.07M | +34.1% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $41.25M | +24.5% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $36.80M | +7.1% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $33.60M | +8.0% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $32.86M | +10.0% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $33.14M | +13.8% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $34.37M | +15.6% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $31.11M | +16.3% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $29.87M | +16.8% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $29.13M | +24.8% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $29.75M | +37.6% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $26.75M | +16.8% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $25.58M | +100.8% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $23.34M | +101.3% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $21.62M | +83.3% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $22.90M | +153.3% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $12.74M | +71.9% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $11.60M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $11.80M | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $9.04M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $7.41M | – |
See a number that looks wrong?